Science Explorer Back to mapMap
Discussion
Researcher · Incyte (United States) · United States

Peter B. Langmuir

Peter B. Langmuir publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Immunology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Myeloproliferative Neoplasms: Diagnosis and Treatment.

OpenAlex
World rank
#316,862
of 7,710,434 ranked researchers
Rank in United States
#114,530
of 1,627,098
Works
74
Citations
6.3k
Citations per work
85.2
h-index
31
i10-index 35Top 8.2% in Pulmonary and Respiratory Medicine
Peter B. Langmuir

What does Peter B. Langmuir research?

Peter B. Langmuir's work is mostly in Medicine (65%), Immunology and Microbiology (11%).

Health Sciences: 48 works · 64.7% of their workMedicine: 48 works · 64.7% of their workPulmonary and Respiratory Medicine: 22 works · 29.6% of their workOncology: 12 works · 16.1% of their workGenetics: 6 works · 7.5% of their workHematology: 6 works · 7.5% of their workPathology and Forensic Medicine: 3 works · 4.0% of their workEverything else: 18 works · 24.2% of their workLife Sciences: 8 works · 11.1% of their workImmunology and Microbiology: 8 works · 11.1% of their workImmunology: 8 works · 11.1% of their workTHEIR WORKPeter B. Langmuir74works
Life Sciences11%Health Sciences65%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4864.7%
  2. Everything else1824.2%
    1. Immunology and Microbiology811.1%
  1. 1Pulmonary and Respiratory Medicine30% of their works
  2. 2Oncology16% of their works
  3. 3Immunology11% of their works
  4. 4Genetics8% of their works
  5. 5Hematology8% of their works
  6. 6Pathology and Forensic Medicine4% of their works

Research topics

Which keywords describe Peter B. Langmuir's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Chemotherapy, CT Screening, Lung Cancer and Genomic Profiles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Clinical Trials372 topics
  2. Targeted Therapy372 topics
  3. ALK Inhibitors281 topic
  4. EGFR Mutations281 topic
  5. Chemotherapy252 topics
  6. CT Screening161 topic
  7. Lung Cancer161 topic
  8. Genomic Profiles91 topic
  9. JAK2 Mutation91 topic
  10. Myelofibrosis91 topic
  11. Small-Cell Lung Cancer91 topic
  12. Classification81 topic
  13. Lymphoma81 topic
  14. Chemotherapy-Induced Peripheral Neuropathy71 topic
  15. Foxp371 topic
  16. TGF-ß71 topic
  17. Taxanes71 topic
  18. NK Cell Recognition61 topic
  19. Natural Killer Cells61 topic

Where does Peter B. Langmuir work?

Peter B. Langmuir's main affiliation in the publication record is Incyte (United States), United States.

How many publications and citations does Peter B. Langmuir have?

OpenAlex counts 74 works and 6,305 citations for Peter B. Langmuir, an h-index of 31, ranking #316,862 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Peter B. Langmuir. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.